tiprankstipranks
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
US Market
NTLA
Intellia Therapeutics
RESEARCH TOOLSreports
Want to see NTLA full AI Analyst Report?

Intellia Therapeutics (NTLA) Stock News & Sentiment

4,785 Followers
Cathie Wood Makes $14M Bet on Alphabet Stock Ahead of Today’s Q1 Earnings, Buys the Dip in CRWV and Trims Bullish Stake
Premium
Market News
Cathie Wood Makes $14M Bet on Alphabet Stock Ahead of Today’s Q1 Earnings, Buys the Dip in CRWV and Trims Bullish Stake
1d ago
BLSH
CRWV
Cathie Wood Offloads Rocket Lab Stock (RKLB) Despite 3% Jump, Buys the Dip in Intellia (NTLA)
Premium
Market News
Cathie Wood Offloads Rocket Lab Stock (RKLB) Despite 3% Jump, Buys the Dip in Intellia (NTLA)
2d ago
ARKG
ARKK
Intellia Reports Positive Phase 3 Results for HAE Gene Therapy
Premium
Company Announcements
Intellia Reports Positive Phase 3 Results for HAE Gene Therapy
3d ago
8K
NTLA
Intellia Therapeutics: Buy Rating Reiterated on Lonvo-z Phase 3 HAELO Upside Potential; $29 Price Target Maintained
Premium
Ratings
Intellia Therapeutics: Buy Rating Reiterated on Lonvo-z Phase 3 HAELO Upside Potential; $29 Price Target Maintained
3d ago
NTLA
Intellia Therapeutics Adopts Fourth Amended and Restated Bylaws
Premium
Company Announcements
Intellia Therapeutics Adopts Fourth Amended and Restated Bylaws
20d ago
8K
NTLA
Balancing Reduced Regulatory Risk and Ongoing Development Uncertainty: Rationale for Maintaining a Hold Rating
Premium
Ratings
Balancing Reduced Regulatory Risk and Ongoing Development Uncertainty: Rationale for Maintaining a Hold Rating
2M ago
NTLA
Intellia Resumes Key Trial and Expands ATM Program
Premium
Company Announcements
Intellia Resumes Key Trial and Expands ATM Program
2M ago
8K
NTLA
More NTLA News >

NTLA News on the Web

2 Healthcare Stocks to Buy and 1 to Approach With Caution
The Motley Fool
Bearish
Intellia Therapeutics Adopts Fourth Amended and Restated Bylaws
TipRanks News
Neutral
NTLA’s Lonvo-z Therapy Shows 96% Reduction in HAE Attacks: New Data Highlights Potential One-Time Treatment
Market Chameleon
Neutral
Bank of America Securities Reaffirms Their Hold Rating on Intellia Therapeutics (NTLA)
TipRanks News
Neutral
Take the Zacks Approach to Beat the Markets: LiveOne, Micron, Clorox in Focus
Zacks
Bullish
Take the Zacks Approach to Beat the Markets: Starbucks, Amgen, Allogene in Focus
Zacks
Bullish
NTLA Awards 16,500 RSUs to New Employees Under Strategic Inducement Plan
Market Chameleon
Neutral
This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy?
The Motley Fool
Neutral

News Score - Last 7 Days

Negative
NTLA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week0%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NTLA’s Media Buzz Sentiment?
1 articles about NTLA were published this week. In an average week, 1 articles are published.
    What is NTLA’s weekly average amount of articles?
    In an average week, 1 articles about NTLA are published.
      What is NTLA’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      TVTXTravere Therapeutics
      HVOOpen Orphan Plc
      PBMPsyence Biomedical
      QDELQuidelOrtho
      Showing the stocks with the most bullish news sentiment over the past week